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Abstract-Microwave irradiation focused on the head of small rodents is now widely used as a means 
of more accurately measuring acetylcholine, choline, cyclic AMP, and several other important brain 
constituents. Because of its probable neurotransmitter role and rapid turnover, a similar approach 
was taken to study brain histamine. Histamine was measured by a modified radio-enzymatic method 
and was found to be nearly tripled in brains from microwave treated rats, compared to decapitation 
controls (124 vs 42 ng/g). Possible explanations include a microwave-induced inactivation of histamine 
breakdown, a microwave-induced redistribution of previously unmeasured histamine, and microwave- 
induced histidine decarboxylation. Brain histamine remained unchanged up to 30 min after decapitation 
and microwave heated brains from decapitated rats also had elevated histamine levels, indicating that 
brain histamine levels in decapitated rats do not represent the remainder of a rapidly depleting pool. 
No evidence for previously unmeasured histamine was found. Furthermore, microwave irradiation 
did not enhance the formation of [3H]histamine after intraventricular C3H]histidine administration, 
indicating a lack of microwave-induced histidine decarboxylation. It is concluded that the elevation 
in rat brain histamine after focused microwave irradiation is probably not artifactual, although the 
mechanism responsible for this phenomenon remains obscure. 
THE APPLICATION of focused microwave irradiation to 
the head of experimental animals facilitates the accu- 
rate measurement of several important substances by 
rapidly inactivating brain protein. G U I ~ ~ T I  et al. 
(1974) demonstrated the importance of this method 
for determining cyclic nucleotide content. Further- 
more, the use of microwave heating is necessary for 
accurately measuring acetylcholine and choline (GUI- 
wrn et al., 1974; STAVINOHA et al., 1973). More 
recently, several other putative neurotransmitter 
levels have been measured using this method (WEIN- 
TRAUB et al., 1975; RICHARDSON & SCUDDER, 1976). 
A variety of evidence exists suggesting histaminer- 
gic transmission in many species (SCHWARTZ, 1975; 
TAYLOR, 1975). Since TAYLOR & SNYDER (1971) 
reported that brain histamine was elevated after im- 
mersion of rats in liquid nitrogen and because a rapid 
turnover of brain histamine exists (POLLARD et al., 
1974; DISMUKES & NYDER, 1974), the effect of focused 
microwave irradiation on rat brain histamine was 
studied. Hypotheses regarding the effects observed 
have been postulated and tested as described in this 
paper. 
A preliminary form of this research was presented at 
the Fall Meetings of the American Society for Pharma- 
cology and Experimental Therapeutics in August, 1975 
(HOUGH & DOMINO, 1975). 
Predoctoral Fellow of USPHS Training Grant 5-TO1 
GM-00198. 
MATERIALS AND METHODS 
Male albino rats (Holtzman) weighing 200-400g were 
maintained in 12 h light-dark cycles and used for all 
studies. Animals were either decapitated at  room tempera- 
ture (22-24°C) or subjected to microwave irradiation fol- 
lowed by decapitation 2 4 h  into the light cycle. The 
microwave oven was a Litton model 70/50 adapted so that 
1.3 kW is focused and pulsed on the rat's head. Rats were 
secured in a suitable restrainer and were killed by 3 4  s 
of microwave heating. This treatment routinely heats the 
brain to 7MO"C. Brains were removed, weighed, and 
homogenized in 4 ml of ice cold 0.05 M-sodium phosphate 
buffer, pH 7.9 containing 0.1% Triton X-100 in 3@45 s un- 
less otherwise specified. Homogenates were placed in a 
boiling water bath for IOmin, cooled in ice, and centri- 
fuged for 20min at 20,0008. Supernatants or pellets were 
measured by the radioenzymatic method of TAYLOR &
SNYDER (1971), as modified by BEAVEN et al. (1971). 
Samples or histamine standards (Sigma) were incubated 
with ['4CH3]S-adenosyl-~-methionine (New England Nuc- 
lear) and [G-3H]histamine in the presence of a partially 
purified histamine methyltransferase (BFAVEN et al., 197 1). 
In other studies, side chain C3H]histamine was synthesized 
according to the method of BEAVEN (1975) and used in 
place of [G-3H]histamine. The reaction was terminated by 
the addition of 0.4 N HC104 containing 1 mg/ml 1,4-meth- 
yl-histamine hydrochloride (Calbiochem). The labeled 
methylhistamine was extracted into chloroform after treat- 
ment with 1 0 ~  NaOH. The chloroform fraction was 
washed with 3 N NaOH and evaporated in a scintillation 
vial under nitrogen. Ten ml of toluene scintillation fluid 
(TAYLOR & SNYDER, 1971) was added and the and 
3H counted in a Beckman LS-200. The 14C/3H ratio is 
linear with histamine concentration from 0.1-2.0 ng. Paper 
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chromatographic analyses of the chloroform extracts were 
carried out using the solvent systems of TAYLOR & SNYDER 
(1971). Histamine values were expressed as ng histamine 
(free base) per g brain wet weight and per mg brain protein. 
Protein was assayed per LOWRY et al. (1951). Brain homo- 
genates from decapitated rats were also placed in 10ml 
vials and microwave heated for 6 S. 
The pellets obtained from heated homogenates were 
assayed for histamine after they were resuspended in 3 ml 
of the phosphate buffer. One ml of 10 N NaOH was added 
and the mixture was mechanically extracted with lOml 
of n-butanolxhloroform (3:2) for 30 min. Following centri- 
fugation (1000 g) the organic layer was removed, evapor- 
ated to dryness under nitrogen and resuspended in 2ml 
of the buffer. The solution was assayed directly or purified 
by diluting to 8ml with buffer followed by ion exchange 
chromatography using 4 x 0.75cm beds of Biorex 70 
(200-400 mesh, Biorad) equilibrated in buffer. The columns 
were washed twice with Sml H,O, followed by elution 
with 2 ml 1 N HC1 and 2 ml H,O. The eluates were com- 
bined, evaporated to dryness in uacuo, resuspended in 
buffer and assayed. Total recovery was determined both 
by the addition of histamine to aliquots of samples and 
with C3H]histamine. All results are corrected for recovery. 
In other experiments rat brain homogenates were purified 
by adding supernatants directly to the columns without 
prior extraction. 
For intraventricular injections of [’Hlhistidine, chronic 
intraventricular cannulae were surgically implanted into 
the lateral ventricle by the method of DEBALBIAN-VERSTER 
et al. (1971). The ~-[2,5-’H]histidine (60mCi/mmol) 
(Amersham-Searle) was purified prior to injection by 
chromatography on ITLC type SG paper (Gelman, Ann 
Arbor) with n-propanol-1 N NH,OH (3: 1). After air dry- 
ing, the area corresponding to genuine histidine was cut 
out, eluted into 4ml H20 ,  filtered through a millipore 
filter. evaporated to dryness. and resuspended in 0.9% 
NaCI to a concentration of I @/PI. Rats received intraven- 
tricular injections of 20 PI of this solution. Thirty min later, 
the animals were either decapitated or subjected to micro- 
wave treatment. Brains were removed, homogenized in 
lOml 0 . 4 ~  HCIOL and centrifuged (20,OOOg x 10min). 
Aliquots (0.1 ml) were added to 10 ml Aquasol (New Eng- 
land Nuclear) and counted for total radioactivity. Five ml 
of H,O containing lOmg histidine, I mg histamine, 1 mg 
methylhistamine were added to 3 ml of the supernatant 
fraction. The pH was adjusted to 8.0 with 1 N NaOH; an 
additional 1 ml of 0.2 N Tris buffer (Sigma), pH 8.0, was 
added. This solution was added to the Biorex columns 
described above. These were washed twice with lOml of 
0.01 N HC1 and eluted with 2 ml of 1 N HCI. Two 0.9 ml 
aliquots of the eluate from each column were made basic 
with 0.3 ml 10 N NaOH and saturated with NaCI. One 
aliquot was extracted with 5 ml of n-butanol-chloroform 
(3:2) and the other with 5 ml chloroform for 30 min. Each 
organic fraction was washed with 5 ml 2 N NaOH, evapor- 
ated under nitrogen and counted. Two million c.p.m. of 
pure C3H]histidine added to a brain homogenate and 
taken through this procedure yielded only 100c.p.m. in 
the butanokhloroform and 45 c.p.m. in the chloroform 
extracts. Recoveries of labeled histamine and methylhista- 
mine (synthesized according to BEAVEN & JACOBSON (1971) 
were 65% in the butanolxhloroform samples. The recov- 
ery in chloroform was 60% of methylhistamine but less 
than 3% of histamine. This method was developed by 
modification of the methods of POLLARD et al. (1974) and 
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FIG. 1. Rat whole brain histamine after decapitation and 
focused microwave irradiation. In this and subsequent 
figures mean whole brain histamine i S.E. for groups of 
8 animals are shown. Microwave irradiation was for 3-6 s. 
Note the marked elevation in brain histamine after the 
microwave treatment. 
SNYDER et al. (1964). Results are corrected for recovery 
and are expressed as labeled histamine and methylhista- 
mine formed in each brain divided by the total label found 
in each brain. The identity of the contents of the organic 
extracts was verified by paper chromatography as de- 
scribed above. 
RESULTS 
The rat brain histamine content after microwave 
irradiation was nearly tripled compared to decapi- 
tation controls (124 5 vs 42 8 ng/g, Fig. 1). 
Because of the stress associated with the restrainer. 
a necessary control was decapitation with the res- 
trainer. Values obtained in this manner were identical 
t o  decapitation controls. Microwave irradiation 
applied to histamine standards was without effect. 
Evidence that histamine was being specifically and 
accurately measured was obtained. Brain homo- 
genates from microwave-treated rats were assayed 
and the resulting chloroform extracts were chromato- 
graphed. More than 95% of the total radioactivity 
co-chromatographed with methylhistamine in two dif- 
ferent solvent systems. The recovery of unlabeled his- 
tamine added to such brain homogenates was always 
greater than 90%. Results identical t o  those in Fig. 
I were also found when brains were homogenized in 
0.4 N HCIO, and subsequently purified by organic 
extraction. When supernatants from the brains of 
decapitated or microwave-treated rats were purified 
by ion exchange chromatography, the histamine 
values measured were identical to those obtained 
from the assay of unpurified samples (Fig. 2). 
Three explanations seem possible for the micro- 
wave-decapitation discrepancy: ( 1 )  that microwave 
treatment arrests a rapid enzymatic process which 
metabolizes histamine under conditions of decapi- 
tation, (2) that microwave treatment liberates some 
‘bound’ histamine not found in the supernatant after 
decapitation, o r  ( 3 )  that  microwave treatment pro- 
duces histamine from some other substance. 
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FIG. 2. Rat whole brain histamine after decapitation and focused microwave irradiation with and 
without cation exchange chromatography. The data are similar to those of Fig. 1 except that the 
supernatant fractions from the heated brain homogenates were purified by cation exchange chroma- 
tography. The histamine content (corrected for recovery) from the purified samples are identical to 
those assayed directly. Note the elevation after microwave. 
In order to attempt to show a rapid post-mortem 
decline in brain histamine, brains were removed and 
assayed at various times after decapitation (Fig. 3). 
A rapid loss of brain histamine was not found. In 
fact, brain histamine was not changed up to 30min 
after decapitation, but was reduced by 50% after 
60min. If brain histamine values found after decapi- 
tation represent the remainder of a rapidly depleting 
metabolic pool, then microwave treatment of a rat 
brain after decapitation (which has low histamine 
content) should not elevate the histamine content. 
The histamine content after such treatment was ele- 
vated, however (Fig. 4). In fact, histamine levels found 
after microwave irradiation of an isolated brain were 
indistinguishable from those of a rat killed by micro- 
wave heating. Homogenates of brains from decapi- 
tated rats did not have higher histamine levels after 
microwave heating. Rat brain histamine also 
remained unchanged when animals were immersed in 
liquid nitrogen for 20 s prior to decapitation. 
If the microwave treatment were causing a redistri- 
bution of histamine from pellet to supernatant, the 
pellet produced by heating and centrifuging brain 
homogenates from decapitated rats should contain 
histamine in sufficient quantity to account for the 
microwave-decapitation discrepancy. Analysis of such 
pellets by direct assay after extraction revealed 
275 f 15ng/g histamine present (Table 1). This rep- 
resents over five times the histamine believed to be 
in the total brain and was therefore suspect. After 
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FIG. 3. Time course of rat whole brain histamine after decapitation. The x-axis represents the time 
the head sat at room temperature prior to brain removal and subsequent histamine analysis. At  60min 
a significant decrease in brain histamine was observed. 





FIG. 4. Rat whole brain histamine after microwave irradia- 
tion of isolated brains. Animals were decapitated, their 
brains removed and assayed directly (column 1) or the iso- 
lated brains heated by microwave (column 3). The animals 
in column 2 were killed by microwave irradiation in uiuo. 
Note that elevated brain histamine levels occur after both 
microwave procedures. 
purification of these pellet extracts, no histamine was 
found, although histamine added to similar extracts 
had a recovery of greater than 50%. Calculations 
based on the maximum sensitivity of the method indi- 
cate that pellets had less than 7 ng/g histamine, 
whether from decapitated or microwave-treated rats. 
If histamine levels were elevated by microwave- 
induced histidine decarboxylation, the accumulation 
of C3H]histamine following C3H]histidine administra- 
tion should be enhanced after microwave treatment. 
TABLE 1. HISTAMINE CONTENT OF BRAIN 
Therefore, ['Hlhistamine and ['Hlmethylhistamine 
were measured 30 min after the intraventricular ad- 
ministration of [3H]histidine under conditions of 
decapitation or microwave treatment. The ratio of 
[3H]histamine/total 'H was not significantly different 
in microwave-treated animals compared to that found 
after decapitation (Table 2). Labeled methylhistamine 
accumulation was also unchanged. 
DISCUSSION 
Although the radioenzymatic histamine assay has 
been validated and widely used recently (BEAVEN, 
1975; BLUMENTHAL et al., 1974), we have substan- 
tiated the identity of the radiochemical product 
obtained from the assay of brains after microwave 
treatment. We have also assayed brains with and 
without partial purification and the results are identi- 
cal. Furthermore, microwave irradiation does not 
affect the determination of histamine standards. These 
findings have convinced us that this method is reliable 
for brain histamine under these circumstances. 
There is little doubt that brain histamine is drasti- 
cally elevated after microwave treatment. Although 
rats frequently appeared stressed during restraint, this 
was not responsible for the microwave effect, since 
decapitation from the restrainer did not change the 
values found after decapitation alone (Fig. 1). The 
brains from microwave treated rats usually weighed 
slightly less than those from decapitated rats but this 
is not responsible for a 3-fold difference. When results 
are expressed as ng histamine per mg of brain protein, 
the elevation is still nearly 3-fold (decapitation: 
0.38 ng/mg; microwave: 0.98 ng/mg). 
PELLETS BEFORE AND AFTER PURIFICATION 
Pellet contents Pellet contents 
(direct extraction) (purified) 
Method of death mean (ng/g) f S.E. mean (ng/g) S.E 
Decapitation 
Microwave 
215 f 15 
305 f 18 
<I  
<I  
Rats were killed by the method indicated and their brains were weighed, homogen- 
ized and heated. Pellets obtained by centrifugation were assayed for histamine after 
organic extraction alone and after subsequent ion exchange chromatography. Each 
value is the mean of 8 determinations. See Methods section for details. 
TABLE 2. EFFECT OF MICROWAVE IRRADIATION ON ['H]HlSTAMlNE AND C3H]METHYLHlS- 
TAMINE CONTENT AFTER INTRAVENTRICULAR [3H]HISTlDINE 
Ratio of C3H]histamine/ Ratio of C3H]methyl 
Method of death total 3H histamine/total 3H 
Decapitation 
Microwave 
0.00291 f 0.00039 0.00059 0.00019 
0.00263 If: 0.00036 0.00059 f 0.00019 
Rats received intraventricular injections of purified C3H]histidine (20 pCi in 20 pl). 
Thirty min later, animals were either decapitated or subjected to microwave irradia- 
tion. Brains were removed, homogenized, and assayed for C3H]histamine, C3H]methyl- 
histamine, and total 3H. Results are expressed as ratios of labeled amine to total 
label and are means of 8 i S.E. of these ratios. In a typical animal 1,316,159 c.p.m. 
total 3H is recovered, of which 4230 c.p.m. are histamine and 858 c.p.m. are methylhis- 
tamine. 
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If a rapid metabolic loss of histamine were occur- 
ring after decapitation, then microwave treatment in 
viuo might be expected to prevent such a loss. This 
could provide for a more accurate measurement of 
histamine. However, microwave treatment of a brain 
after decapitation (at a time when the presumed loss 
has alraedy occurred) should not elevate the histamine 
content. Our results clearly demonstrate that such ele- 
vation does occur (Fig. 4). This experiment is necess- 
ary in any system where microwave-induced inactiva- 
tion of enzymes is hypothesized as the mechanism 
of the microwave effect. Whereas the measurement 
of enzyme activity after various microwave treatments 
provides a correlation (albeit an important one), the 
conclusion from the present experiment can be defini- 
tive. In this case we believe that it is: the elevation 
in brain histamine after microwave irradiation is not 
due to an inactivation of rapid catabolic processes. 
Our other evidence is also consistent with this con- 
clusion. No rapid loss of brain histamine was found 
after decapitation (Fig. 3). When brain protein is 
denatured by homogenizing in acid, the histamine 
content after decapitation is the same as in samples 
homogenized and heated in buffer. This would not 
be expected if rapid metabolic changes were occur- 
ring, since the acid treatment inactivates protein 
2&30 s faster than does heating the samples in buffer. 
We have also measured rat brain histamine in ani- 
mals killed by immersion in liquid nitrogen, a pro- 
cedure sometimes used to minimize postmortem enzy- 
matic changes (APRISON et al., 1974). This treatment 
had no effect on brain histamine compared to decapi- 
tation. 
It would appear that the microwave effect does 
require a morphologically intact brain, since micro- 
wave treatment of brain homogenates from decapi- 
tated rats did not elevate the histamine content. 
Further interpretation of this observation seems diffi- 
cult, although this inability to demonstrate histamine 
elevation in uitro argues against a microwave-induced 
conversion of other substances to histamine. It should 
be pointed out, however, that in the present experi- 
ments the brain homogenates were at 4°C prior to 
microwave treatment. RICHARDSON & SCUDDER (1976) 
have shown that the ability of microwave irradiation 
to alter brain GABA levels is a function of the initial 
brain temperature. These observations may be rele- 
vant to our results with microwave treated homo- 
genates although this treatment clearly heated the 
sample and denatured the protein present. 
The histamine content found after analysis of the 
unpurified brain pellet was shown to be artifactual 
by subsequent purification. The artifact is not found 
after organic extraction of supernatant fractions, since 
reasonable whole brain histamine values have been 
obtained this way. Homogenates extracted in this 
manner prior to heating or centrifugation were also 
found to be spuriously elevated. The identity of this 
heat stable, lipid soluble artifact is not known. 
Assuming that most of the histamine in the pellet 
is freed by extraction, it seems clear that little or no 
histamine is actually in the pellet. Theoretically, 
extraction-resistant histamine could be in the pellet 
and be freed by microwave treatment. Unless hista- 
mine were bound covalently, however, the solvent 
should have removed it. We have also sonicated these 
pellet homogenates prior to extraction, with no differ- 
ence in the results obtained. 
It seemed important to find out if microwave treat- 
ment could decarboxylate histidine in vim, since 
many amine artifacts could be produced and 
measured this way. A conversion of 1-2% of brain 
histidine to histamine could explain the observed 
changes in histamine content, since histidine levels are 
so much higher (ENWONWU & WORTHINGTON, 1975). 
Thirty minutes after the 20 pCi injection of ['Hlhisti- 
dine, 6 7 %  of the label remains in brain, of which 
85-90% remains as histidine. Thus, a decarboxylation 
of 1% of this histidine would have enhanced the 
labeled histamine found from about 3000 to 
15,000 c.p.m., and the [3H)histamine/3H-total ratio 
would have been proportionately elevated. 
Since no difference was found between the ratios 
from decapitated and microwave treated rats, it can 
be concluded that microwave-induced histidine decar- 
boxylation does not occur. This conclusion requires 
the assumption that the labeled amino acid reached 
all endogenous compartments associated with hista- 
mine synthesis. The work of DISMUKES & SNYDER 
(1974) supports this assumption by demonstrating a 
similar turnover rate of brain histamine measured by 
isotopic and non-isotopic techniques. The isotopic 
technique used by these investigators is identical to 
the one used presently. The 30min time point was 
chosen because this is near the time of maximum 
labeled histamine present (POLLARD et al., 1974). This 
labeled histamine found after 30 min further substan- 
tiates the rapid kinetics of brain histamine found by 
others (POLLARD et al., 1974; DISMUKES & SNYDER, 
1974). In addition, the lack of microwave effect further 
argues against an inactivation of rapid metabolic pro- 
cesses since labeled histamine was measured at a time 
when both decarboxylation and methylation were 
occurring (POLLARD et al., 1974). 
We have shown that rat brain histamine content 
is elevated after focused microwave irradiation. This 
elevation is not due to an artifact in measuring hista- 
mine, is not due to an inactivation of rapid metabolic 
processes, is not attributable to histamine redistribu- 
tion, is not due to histidine decarboxylation, but is 
dependent upon intact brain morphology. Micro- 
wave-induced formation of histamine from other sub- 
stances seems unlikely but remains the only plausible 
explanation. Metabolic formation of histamine from 
substances other than histidine is not known. We 
have also shown that histamine measurements using 
the radioenzymatic assay are unreliable if extractions 
are made from non-denatured homogenates without 
subsequent purification. 
Elevations per se in neurotransmitter content fol- 
204 L. B. HOUGH and E. F. DOMINO 
lowing microwave treatment should not be construed 
as evidence for a more accurate measurement of that 
substance. Neither should it be construed as evidence 
for a system with a rapid turnover, as others have 
suggested (MERRITT et al., 1975). Systems with rapid 
rates of turnover do not necessarily demonstrate 
rapid post-mortem changes. Only when synthesis and 
degradation become unbalanced d o  rapid changes in 
content occur, as is apparently the case for post-mor- 
tem acetylcholine (STAVINOHA et al., 1973). Our results 
demonstrate that this is not the case for histamine. 
Note added in proof: Recently two groups of investigators 
have reported that brain tissue forms peptido-histamines 
[REICHELT et al. (1976) J .  Neurochem. 26, 811-815 and 
KONISHI & KAKIMOTO (1976) J. Neurochem. 27, 
1461-14631. One should examine the possibility that 
microwave treatment could be forming histamine from 
such substances endogenously. 
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